日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor-reactive TCRs within exhausted TILs reveal cancer type-specific immune landscapes in renal cell carcinoma.

耗竭的 TIL 中的肿瘤反应性 TCR 揭示了肾细胞癌中癌症类型特异性的免疫图谱。

Komahashi Mitsuru, Horaguchi Shun, Tsuji Kayoko, Hoshino Daisuke, Kishida Takeshi, Usui Kimitsugu, Nakaigawa Noboru, Sato Shinya, Hamana Hiroshi, Kishi Hiroyuki, Wei Feifei, Mano Yasunobu, Kouro Taku, Uehara Shuichiro, Sasada Tetsuro

Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer

胃癌患者网膜乳斑中免疫细胞的特征及临床意义

Mano, Yasunobu; Igarashi, Yuka; Komori, Keisuke; Hashimoto, Itaru; Watanabe, Hayato; Takahashi, Kosuke; Kano, Kazuki; Fujikawa, Hirohito; Yamada, Takanobu; Himuro, Hidetomo; Kouro, Taku; Wei, Feifei; Tsuji, Kayoko; Horaguchi, Shun; Komahashi, Mitsuru; Oshima, Takashi; Sasada, Tetsuro

Machine learning-based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors

基于机器学习的对接受免疫检查点抑制剂治疗的非小细胞肺癌患者循环自身抗体动态和治疗结果的深入分析

Wei, Feifei; Takeda, Hiroyuki; Azuma, Koichi; Nakahara, Yoshiro; Igarashi, Yuka; Murotani, Kenta; Saito, Haruhiro; Murakami, Shuji; Kondo, Tetsuro; Kouro, Taku; Himuro, Hidetomo; Tsuji, Kayoko; Komahashi, Mitsuru; Sawasaki, Tatsuya; Sasada, Tetsuro

Association between soluble immune mediators and outcomes in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumab

可溶性免疫介质与接受同步放化疗后序贯度伐利尤单抗治疗的不可切除的III期非小细胞肺癌患者预后之间的关联

Tokito, Takaaki; Azuma, Koichi; Murotani, Kenta; Matsuo, Norikazu; Matama, Goushi; Murata, Daiki; Sasada, Tetsuro; Hoshino, Tomoaki

Multi-omics analysis-based clinical and functional significance of a novel prognostic and immunotherapeutic gene signature derived from amino acid metabolism pathways in lung adenocarcinoma

基于多组学分析的肺腺癌氨基酸代谢通路衍生的新型预后和免疫治疗基因特征的临床和功能意义

Xiang, Huihui; Kasajima, Rika; Azuma, Koichi; Tagami, Tomoyuki; Hagiwara, Asami; Nakahara, Yoshiro; Saito, Haruhiro; Igarashi, Yuka; Wei, Feifei; Ban, Tatsuma; Yoshihara, Mitsuyo; Nakamura, Yoshiyasu; Sato, Shinya; Koizume, Shiro; Tamura, Tomohiko; Sasada, Tetsuro; Miyagi, Yohei

Characterization of pre- and on-treatment soluble immune mediators and the tumor microenvironment in NSCLC patients receiving PD-1/L1 inhibitor monotherapy

对接受 PD-1/L1 抑制剂单药治疗的非小细胞肺癌患者治疗前和治疗期间可溶性免疫介质及肿瘤微环境进行表征

Murata, Daiki; Azuma, Koichi; Murotani, Kenta; Kawahara, Akihiko; Nishii, Yuuya; Tokito, Takaaki; Sasada, Tetsuro; Hoshino, Tomoaki

Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation

增强基于质谱的肿瘤免疫肽鉴定:利用HLA结合亲和力、脂肪族指数和保留时间偏差的机器学习过滤器

Wei, Feifei; Kouro, Taku; Nakamura, Yuko; Ueda, Hiroki; Iiizumi, Susumu; Hasegawa, Kyoko; Asahina, Yuki; Kishida, Takeshi; Morinaga, Soichiro; Himuro, Hidetomo; Horaguchi, Shun; Tsuji, Kayoko; Mano, Yasunobu; Nakamura, Norihiro; Kawamura, Takeshi; Sasada, Tetsuro

Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer

放射疗法在间变性甲状腺癌治疗中的最新趋势和潜力

Sekihara, Kazumasa; Himuro, Hidetomo; Toda, Soji; Saito, Nao; Hirayama, Ryoichi; Suganuma, Nobuyasu; Sasada, Tetsuro; Hoshino, Daisuke

MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors

MMP1、IL-1β、sTNFR-1 和 IL-6 是接受免疫检查点抑制剂治疗的不可切除或转移性肾细胞癌患者的预后因素。

Nagasaka, Hirotaka; Kishida, Takeshi; Kouro, Taku; Igarashi, Yuka; Takebe, Shinichi; Yamamoto, Shotaro; Kondo, Takuya; Koizumi, Mitsuyuki; Terao, Hideyuki; Suzuki, Takahisa; Nakaigawa, Noboru; Himuro, Hidetomo; Wei, Feifei; Sasada, Tetsuro

Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures

基于循环细胞因子特征的机器学习在非小细胞肺癌免疫治疗结果预测中的应用

Wei, Feifei; Azuma, Koichi; Nakahara, Yoshiro; Saito, Haruhiro; Matsuo, Norikazu; Tagami, Tomoyuki; Kouro, Taku; Igarashi, Yuka; Tokito, Takaaki; Kato, Terufumi; Kondo, Tetsuro; Murakami, Shuji; Usui, Ryo; Himuro, Hidetomo; Horaguchi, Shun; Tsuji, Kayoko; Murotani, Kenta; Ban, Tatsuma; Tamura, Tomohiko; Miyagi, Yohei; Sasada, Tetsuro